We are the clinic in the UK to offer the EyeMax Mono lens that can help improve vision for those living with age-related macular degeneration.
Age-related macular degeneration (AMD) affects the central vision, eventually leading to loss of sight, and is the most common cause of blindness in over 55s in the developed world. With no cure, AMD sufferers were often left with no option but a lengthy, complicated and invasive procedure, but not any more…
Bobby Qureshi, Chief Medical Officer and Founder of the London Eye Hospital Pharma joined forces with a world-renowned optical physicist and together they came up with a low-risk, simple procedure that could save the sight of millions worldwide.
The new EyeMax lens works by gently magnifying and diverting images away from the damaged part of the eye to the healthy parts. The EyeMax lens implant works in tandem with a pair of prescription glasses to realise its full visual potential.
Whilst there is still no cure for age-related macular degeneration, this AMD Lens treatment, available at the London Eye Hospital can restore your vision and allow you to get your life back on track.
To find out more and see if you may be suitable, please fill in the form and we will be in touch.
Irene Da Silva – Plymouth
“Irene, a retired classroom assistant from Plymouth, who has not seen her granddaughter’s face for two years, will finally be able to see her again following a revolutionary treatment at the leading private London Eye Hospital on Harley Street. Irene could make out outlines and shapes of people, but was unable to see their facial features….”
London Eye Hospital’s Bobby Qureshi says:
“Irene was gradually losing her independence, which she understandably found incredibly upsetting. This, coupled with her desire to see her granddaughter’s face again, gave her the impetus to undergo the EyeMax procedure. We were delighted that she was suitable for treatment, and just as delighted that it has helped her regain her sight. The EyeMax implant for AMD is a giant step forward in optical innovation.”
We aware of the article published on Sunday, 13 August on the Mail Online about Mr Qureshi and the London Eye Hospital. Whilst the Hospital cannot comment on individual cases due to patient confidentiality obligations, we are confident that no patients have been misled. Patient care remains a priority for the Hospital and we would happily discuss concerns that any patients may have in relation to their past or prospective surgery. Mr Qureshi is fully cooperating with the GMC investigation but it would not be appropriate to comment further at this stage other than to say that he expects that the GMC will exonerate him in its investigation.
Mr Qureshi remains a leading ophthalmologist in the UK whose work at the London Eye Hospital is pioneering and has helped significant numbers of individuals suffering from degenerative macular disease to have improved vision over a prolonged period.
0207 060 2602